News

OneMedNet Welcomes Bob Golden as New Chief Financial Officer

OneMedNet Welcomes Bob Golden as New Chief Financial Officer

OneMedNet Appoints Bob Golden as CFO

OneMedNet Corporation (NASDAQ: ONMD), a leader in regulatory-grade Real World Data (RWD), has appointed Bob Golden as Chief Financial Officer. The move strengthens the company’s executive bench at a time of continued growth. As CFO, Golden will lead OneMedNet’s financial and accounting operations and support the company’s next phase of execution and scale.

About Bob Golden and His Expertise

Bob Golden, a Certified Public Accountant, brings more than four decades of hands-on financial management experience. Since 2015, he has served as Managing Partner at Cohen, Bender & Golden LLP, advising mid-market businesses on accounting, controls, and performance improvement. He has also held Chief Financial Officer roles at Promo Shop, Inc. and iKahan Media, Inc., roles in which he sharpened his focus on operational efficiency, financial planning, and strategic growth initiatives. That mix of advisory and operating work is central to the role he steps into now.

Achievements and Background

Over his career, Golden has consistently focused on improving profitability and optimizing cash flow. His experience includes mergers and acquisitions, adding a seasoned perspective to OneMedNet’s leadership team. He has also served on the Board of Directors of Talon International, Inc. since 2013, contributing to the growth of the world’s largest zipper manufacturer and gaining additional oversight and governance experience along the way.

Strategic Importance of This Appointment

Golden’s arrival comes at a pivotal moment as OneMedNet advances and expands its iRWD™ platform. According to Aaron Green, President & CEO, Golden’s deep background in financial strategy and business development will help the company navigate market expansion and strengthen commercial outreach across the global life sciences sector. In short, the hire aligns the company’s financial leadership with its product and go-to-market ambitions.

Company Vision and the iRWD™ Platform

OneMedNet’s iRWD™ platform brings together clinical data from more than 1,400 healthcare systems. It handles electronic health records, laboratory results, and medical imaging—and does so by securely de-identifying and curating data for responsible use. With this foundation, OneMedNet enables research opportunities for clients working in drug development, AI diagnostics, and other data-driven healthcare initiatives, while maintaining a regulatory-grade approach to data quality.

Commitment to Healthcare Innovation

The company’s mission is clear: improve patient outcomes by supporting rigorous research across key medical areas, including rare diseases and oncology. OneMedNet’s emphasis on quality and innovation shows up in its platform work and in its strategic initiatives aimed at accelerating healthcare advancements. The throughline is practical—deliver high-integrity data that researchers and developers can put to work, securely and at scale.

Former CFO Transition

Lisa Embree, the former CFO, has chosen to pursue new opportunities outside the organization. Her transition opens the door for Golden to apply his experience and bring fresh perspective to the company’s financial leadership and day-to-day operations.

About OneMedNet Corporation

OneMedNet focuses on unlocking the value of Real-World Data through its advanced iRWD™ platform, supporting clinical research and healthcare innovation. By curating high-quality, de-identified data drawn from a broad network of healthcare systems, the company helps teams refine strategies and improve outcomes at a global scale.

Frequently Asked Questions

What will Bob Golden do as CFO?

He will lead OneMedNet’s financial and accounting operations and support the company’s strategic growth plans as it scales its iRWD™ platform and commercial efforts.

What experience does Bob Golden bring to OneMedNet?

Golden has over 40 years of financial management experience, including CFO roles at Promo Shop, Inc. and iKahan Media, Inc., and service as Managing Partner at Cohen, Bender & Golden LLP since 2015. His background spans profitability improvement, cash flow optimization, and mergers and acquisitions.

What is the iRWD™ platform?

It’s OneMedNet’s platform for managing clinical data from more than 1,400 healthcare systems, including electronic health records, lab results, and medical imaging. The data is securely de-identified and curated to support research in areas such as drug development and AI diagnostics.

How does this appointment support OneMedNet’s strategy?

The hire aligns financial leadership with the company’s expansion plans. As noted by President & CEO Aaron Green, Golden’s background in financial strategy and business development will help guide market expansion and enhance commercial outreach in the global life sciences sector.

Who previously served as CFO?

Lisa Embree was the former CFO and has decided to pursue new opportunities outside OneMedNet.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading